FUSN — Fusion Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.83bn
- $1.67bn
- $2.07m
AstraZeneca to buy Fusion Pharma for $2 billion in cash (updated)
AstraZeneca to buy Fusion Pharma for $2 billion in cash
Brief: Fusion Pharmaceuticals To Be Acquired By Astrazeneca, Accelerating Development Of Next-Generation Radioconjugates To Treat Cancer
Fusion Pharmaceuticals Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fusion Pharma dips as co boosts stock offering plan to $200 mln
Brief: Fusion Pharmaceuticals Files For Common Stock Offering Of Up To $100 Mln
U.S. STOCKS ON THE MOVE-CVS Health, Peloton, Eli Lilly
U.S. STOCKS ON THE MOVE-Conagra Brands, Voyager Therapeutics, McDonald's
Fusion climbs on positive data from tumor treatment trial
U.S. STOCKS ON THE MOVE-First Solar, Fusion Pharmaceuticals, MicroStrategy
Fusion Pharmaceuticals rises after Raymond James upgrades to 'strong buy'
Fusion Pharma gains on Bristol Myers-RayzeBio deal
Brief: Deerfield Management Company Reports 8.84% Passive Stake In Fusion Pharmaceuticals Inc
Brief: Bwxt Medical Expands Collaboration With Fusion Pharmaceuticals Through Strengthened Actinium Supply And Access To Generator Technology
Brief: Fusion Pharmaceuticals Strengthens Actinium Supply With Onsite Isotope Production Through Expanded Bwxt Medical Collaboration
Brief: Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Fusion Pharmaceuticals Announces Third Quarter 2023 Financial Results And Clinical Program Updates
Brief: Fusion Pharmaceuticals Announces Third Quarter 2023 Financial Results And Clinical Program Updates